Cargando…
CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction
PURPOSE: Oncology immunity was reported to play a key role in cancer development and progression, so we investigated the prediction role of several immune markers in esophageal squamous cell carcinoma (ESCC) patients after operation in this study. PATIENTS AND METHODS: 66 primary ESCC tumor tissues...
Autores principales: | Li, Jian, Zhang, Bao-Zhu, Qin, Yan-Ru, Bi, Jiong, Liu, Hai-Bo, Li, Yan, Cai, Mu-Yan, Ma, Stephanie, Chan, Kwok Wah, Xie, Dan, Guan, Xin-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941258/ https://www.ncbi.nlm.nih.gov/pubmed/26771842 http://dx.doi.org/10.18632/oncotarget.6900 |
Ejemplares similares
-
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells
por: Li, Jian, et al.
Publicado: (2022) -
Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2023) -
Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020) -
Inhibiting Interleukin-19 Activity Ameliorates Esophageal Squamous Cell Carcinoma Progression
por: Hsing, Chung-Hsi, et al.
Publicado: (2013) -
Down‐regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Wang, Ling, et al.
Publicado: (2018)